News & Industry Bulletins

Wednesday, November 26, 2014

FDA approves extended-release, single-entity hydrocodone product with abuse deterrent properties

The U.S. Food and Drug Administration approved Hysingla ER (hydrocodone bitartrate), an extended-release (ER) opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Hysingla ER has approved labeling describing the product’s abuse-deterrent properties consistent with the FDA’s 2013 draft guidance for industry, Abuse-Deterrent Opioids – Evaluation and Labeling.

Thursday, October 30, 2014

Study Finds Positive Drug Test from Secondhand Marijuana Smoke Unlikely

A new study finds it is unlikely that a person exposed to secondhand marijuana smoke will test positive for marijuana themselves. While it is possible that extreme marijuana smoke exposure could produce a positive urine test, this occurrence is likely to be rare and limited to the hours immediately after exposure, according to researchers from Johns Hopkins University.

Thursday, October 16, 2014

Medical Groups: Pregnant Women Should Be Asked About Drug Use

Several medical groups are calling for verbal drug screening for pregnant women, followed by a urine test if necessary, USA Today reports. The recommendation is meant to reduce the growing number of babies born with neonatal abstinence syndrome (NAS).

Tuesday, October 14, 2014

Leading Medication Monitoring Coalition Announces Election of Robert Garvey to Serve as New Chairman

The Coalition for Excellence in Medication Monitoring (CEMM) – the leading voice of the medication monitoring clinical laboratory industry – has elected Robert Garvey, CEO of Dominion Diagnostics, to serve as its new Chairman.

Tuesday, September 30, 2014

Dominion Diagnostics Now Offers Detection of "Z-Drugs" Commonly Prescribed for Insomnia

Dominion Diagnostics, a leading national provider of drug testing, medication monitoring, and actionable clinical information, now offers a new laboratory‐based urine test for the detection of commonly prescribed Z‐Drugs.

Tuesday, September 23, 2014

Improvement of Abstinence in Chemical Dependence Treatment Programs with Comprehensive Analysis of Reported Drugs (CARD)®

Scientists in the open access journal PLOSONE reported today on a comprehensive systematic evaluation of compliance to prescribed treatment medications and abstinence from psychoactive drug abuse in chemical dependence programs.

Wednesday, August 27, 2014

DEA Bumps Hydrocodone-Combination Products to Schedule II Drugs

The U.S. Drug Enforcement Administration (DEA) has reclassified hydrocodone-combination products as the more restrictive Schedule II drugs in an attempt to curb drug abuse. The DEA published the Final Rule in the Federal Register on Aug. 22. The Final Rule will take effect in 45 days and will apply to “all pharmaceuticals containing hydrocodone currently on the market in the United States.”

Wednesday, August 20, 2014

Methadone Guidelines Focus On Primary Care

New guidelines drafted by the American Pain Society (APS) for the safe administration of methadone for the first time focus particular attention on the potential for abuse and misuse of the drug, highlighting the need for additional awareness and education within the pain management community, after a significant increase in deaths related to its use.

Friday, July 25, 2014

Ten Drugs Cause Majority of ER Visits in Adults for Adverse Psych Med Effects

Nearly 90,000 adults go to emergency rooms each year for side effects of psychiatric medications, and a few specific drugs may be to blame for 57% of those visits, a new study has found.

Thursday, July 17, 2014

Dominion Diagnostics employees donate to Project Sweet Peas, a local RI organizations supporting NICU families

Dominion Diagnostics recently hosted a donation drive to benefit Project Sweet Peas, an organization that provides comfort to families with children in the Women and Infants neonatal intensive care unit (NICU). There are a number of Dominion Diagnostics employees who have been beneficiaries of support services from Project Sweet Peas.